[Federal Register Volume 63, Number 78 (Thursday, April 23, 1998)]
[Notices]
[Pages 20205-20206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10873]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the National Cancer 
Institute Director's Consumer Liaison Group (DCLG), April 30-May 1 at 
the Doubletree Hotel, 1750 Rockville Pike, Rockville, MD.
    This meeting will be open to the public on April 30, 1998 from 9:00 
a.m. to approximately 5:00 p.m., and on May 1 from 9:00 a.m. to 
approximately 2:30 p.m. During this time there will be discussions on: 
consumer/patient issues, rights and concerns regarding participation in 
cancer research including population and genetic studies and clinical 
trials; cancer control; and developing mechanisms to identify consumer 
advocates to serve on NCI program and policy advisory committees.
    The meeting will be closed to the public on May 1 from 
approximately 2:45 p.m. to approximately 4:00 p.m. for discussion of 
confidential issues. These discussions will disclose information of a 
personal nature where disclosure would constitute a clearly unwarranted 
invasion of personal privacy.
    Information pertaining to the meeting may be obtained from Elaine 
C. Lee, in the Office of Liaison Activities, National Cancer Institute, 
Building 31, Room 10A06, 31 Center Drive (MSC-2580), Bethesda, MD 
20892-2580; or by calling telephone no. (301) 594-3194 or sending a fax 
to (301) 480-7558. Attendance by the public will be limited to space 
available. Individuals who plan to attend the meeting and need special 
assistance, such as sign language

[[Page 20206]]

interpretation or other special accommodations, should contact Ms. Lee 
in advance of the meeting.

    Dated: April 16, 1998.
Marvin Kalt,
Director, Division of Extramural Activities, National Cancer Institute.
[FR Doc. 98-10873 Filed 4-22-98; 8:45 am]
BILLING CODE 4140-01-M